Meeting
2013 ASCO Annual Meeting
Serum mass spectrometry analysis in primary ovarian cancer (OC) treated with surgery and adjuvant chemotherapy (CT).
Authors
Heinrich Roder
Biodesix Inc., Boulder, CO
Heinrich Roder , Sabine Kasimir-Bauer , Rainer Kimmig , Pauline Wimberger , Robert Zeillinger , Dan Cacsire Castillo-Tong , Jalid Sehouli , Ignace Vergote , Sven Mahner , Joanna Roder , Julia Grigorieva , Krista Meyer , Bahriye Aktas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 5575)
DOI
10.1200/jco.2013.31.15_suppl.5575
Abstract #
5575
Poster Bd #
48G
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Prognostic significance of familial pancreatic cancer after surgery.
First Author: Koji Tezuka
Poster
2017 ASCO Annual Meeting
Upfront short course radiotherapy (SCRT) in metastatic rectal cancer (mRC): A way forward.
First Author: Shanu Jain
Poster
2017 Gastrointestinal Cancers Symposium
Comparison of irinotecan and oxaliplatin as adjuvant chemotherapy for patients with resectable synchronous colon cancer plus liver-confined metastases: A retrospective nationwide database study.
First Author: Yi-Hsin Liang
Poster
2016 ASCO Annual Meeting
Ewing sarcoma Family of Tumors in Older Patients (EFyTOP): Management and outcome of Ewing sarcoma family of tumors (EFTs) in patients older than 50 years.
First Author: Pauline Rochefort